Nektar Therapeutics | Stammkapital



Ordinary Share Capital Veränderung Datum
Agios Pharmaceuticals USD 74K 1000 2025-03
ALKERMES USD 1.8M 35K 2025-03
Amgen USD 33.58B 45M 2025-03
Baxter International USD 683M 0 2024-12
Biogen USD 100K 0 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
Cipla INR 1.62B 100K 2025-03
Dr.Reddys Laboratories INR 834M 0 2025-03
Eisai JPY 44.99B 0 2025-03
Eli Lilly USD 592.6M 200K 2025-03
Exelixis USD 275K 7K 2025-04
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 1000K 2025-03
Grifols EUR 119.6M 0 2024-12
Halozyme Therapeutics USD 123K 0 2025-03
Incyte USD 193K 0 2025-03
Ionis Pharmaceuticals USD 159K 1000 2025-03
Ironwood Pharmaceuticals USD 160K 0 2024-12
MacroGenics USD 628K 1000 2024-12
Merck USD 1.79B 0 2025-03
Neurocrine Biosciences USD 100K 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 481M 1000K 2025-03
Roche Holding CHF 107M 0 2024-06
Sarepta Therapeutics USD 10K 0 2025-03
Takeda JPY 1.69T 25M 2025-03
Teva Pharmaceutical Industries USD 58M 0 2024-09
Xencor USD 712K 9K 2025-03



Nektar Therapeutics Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.